Won Suk Lee Selected Research

Phosphoric Monoester Hydrolases (Phosphatases)

1/2004	Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells.
9/2003	Cilostazol prevents tumor necrosis factor-alpha-induced cell death by suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and activation of Akt/cyclic AMP response element-binding protein phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Won Suk Lee Research Topics

Disease

23	Neoplasms (Cancer) 03/2024 - 07/2007
8	Ischemia 01/2018 - 03/2004
7	Infarction (Infarctions) 01/2018 - 03/2004
6	Rheumatoid Arthritis 01/2020 - 03/2010
5	Cerebral Infarction 01/2018 - 07/2005
4	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 09/2002
4	Bites and Stings (Sting) 10/2023 - 01/2019
4	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2007
4	Inflammation (Inflammations) 06/2019 - 10/2008
4	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 02/2014
4	Experimental Arthritis 10/2015 - 03/2010
4	Brain Ischemia (Cerebral Ischemia) 04/2011 - 01/2008
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 11/2020
3	Stomach Neoplasms (Stomach Cancer) 10/2021 - 06/2012
3	Brain Injuries (Brain Injury) 01/2018 - 06/2009
3	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 11/2007
3	Atherosclerosis 08/2008 - 05/2005
2	Neuroinflammatory Diseases 01/2023 - 04/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 12/2022
2	Peritoneal Neoplasms 01/2021 - 11/2020
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 08/2019 - 01/2019
2	Vascular Remodeling 01/2019 - 01/2018
2	Hypoxia (Hypoxemia) 04/2015 - 06/2009
2	Arthritis (Polyarthritis) 01/2014 - 11/2013
2	Septic Shock (Toxic Shock Syndrome) 04/2012 - 08/2009
2	Insulin Resistance 05/2009 - 12/2008
2	Neuroblastoma 01/2006 - 01/2004
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2024
1	Neurofibrosarcoma (MPNST) 03/2024
1	Thyrotoxicosis 02/2024
1	Hypothyroidism 02/2024
1	Necrosis 04/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2023
1	Paragonimiasis 03/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Ascites 11/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Urticaria (Hives) 01/2018
1	Vascular System Injuries 01/2018

Drug/Important Bio-Agent (IBA)

24	Cilostazol (Pletal)FDA LinkGeneric 01/2020 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2009
7	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2019
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 09/2003
5	InterferonsIBA 10/2023 - 01/2019
4	CytokinesIBA 02/2024 - 03/2010
4	Sirtuin 1IBA 01/2020 - 01/2014
4	Amyloid (Amyloid Fibrils)IBA 01/2016 - 02/2014
3	Interleukin-6 (Interleukin 6)IBA 02/2024 - 12/2022
3	atezolizumabIBA 02/2024 - 12/2022
3	Bevacizumab (Avastin)FDA Link 02/2024 - 12/2022
3	Interferon Type IIBA 01/2021 - 01/2019
3	Neuroprotective AgentsIBA 08/2019 - 06/2007
3	Aripiprazole (Abilify)FDA Link 08/2019 - 12/2017
3	Peptides (Polypeptides)IBA 01/2016 - 11/2014
3	Glucose (Dextrose)FDA LinkGeneric 10/2014 - 09/2007
3	Carcinoembryonic AntigenIBA 07/2008 - 08/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2023 - 04/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2016
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018 - 04/2011
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018 - 04/2011
2	HMGB1 Protein (HMG1)IBA 01/2018 - 04/2015
2	LipopolysaccharidesIBA 04/2012 - 08/2009
2	Heme Oxygenase-1IBA 03/2010 - 06/2009
2	PPAR gammaIBA 05/2009 - 12/2008
2	Probucol (Lorelco)FDA Link 08/2008 - 07/2007
2	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2006 - 03/2004
2	iberiotoxinIBA 01/2006 - 03/2004
2	Superoxides (Superoxide)IBA 05/2005 - 07/2002
2	TensinsIBA 01/2004 - 09/2003
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2004 - 09/2003
1	monooxyethylene trimethylolpropane tristearate (MTTS)IBA 03/2024
1	Liposomes (Liposome)IBA 10/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	NAD (NADH)IBA 01/2023
1	afliberceptIBA 01/2023
1	Axitinib (AG 013736)IBA 12/2022
1	pembrolizumabIBA 12/2022
1	AntibodiesIBA 12/2022
1	NeodymiumIBA 07/2022
1	Praziquantel (Biltricide)FDA Link 03/2022
1	Toll-Like Receptor AgonistsIBA 01/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Programmed Cell Death 1 ReceptorIBA 11/2020
1	B7-H1 AntigenIBA 11/2020
1	LigandsIBA 06/2019
1	SiliconesIBA 01/2019
1	tranilastIBA 01/2019
1	PolymersIBA 01/2019
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2019
1	caffeic acid phenethyl esterIBA 01/2018
1	Propolis (Bee Bread)IBA 01/2018

Therapy/Procedure

12	Therapeutics 02/2024 - 07/2007
8	Immunotherapy 12/2022 - 01/2019
2	Lasers (Laser) 01/2018 - 06/2009
1	Radiotherapy 03/2024
1	Hysterectomy 03/2024
1	Surgical Instruments (Clip) 07/2022